|
1
|
Prasad ML, Pellegata NS, Huang Y, Nagraga
HN, De la chapelle A and Kloos RT: Galectin-3, Fibronectin-1, CI
TED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for
the differential diagnosis of thyroid tumors. Mod Pathol. 18:48–57.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beesley MF and Mclaren KM: Cytokeratin-19,
galectin-3 immunohistochemistry in the differential diagnosis of
solitary thyroid nodule. Histopathology. 41:236–243. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsukita S, Furuse M and Itoh M:
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.
2:285–293. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rahner C, Mitic LL and Anderson JM:
Heterogenity in expression and subcellular localization of Claudins
2, 3, 4 and 5 in the rat liver, pancreas, and gut.
Gastroenterology. 120:411–422. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Krause G, Winkler L, Mueller SL, Haseloff
RF, Piontek J and Blasig IE: Structure and function of claudins.
Biochim Biophys Acta. 1778:631–645. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ouban A and Ahmed AA: Claudins in human
cancer: A review. Histol Histopathol. 25:83–90. 2010.PubMed/NCBI
|
|
7
|
Will C, Fromm M and Müller D: Claudin
tight junction proteins: Novel aspects in paracellular transport.
Perit Dial Int. 28:577–584. 2008.PubMed/NCBI
|
|
8
|
Oliveira SS and Morgado-Diaz JA: Claudins:
Multifunctional players in epithelial tight junctions and their
role in cancer. Cell Mol Life Sci. 64:17–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bornholdt J, Friis S, Godiksen S, Poulsen
SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM,
Johnson E, et al: The level of claudin-7 is reduced as an early
event in colorectal carcinogenesis. BMC Cancer. 11:652011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Németh J, Németh Z, Tátrai P, Péter I,
Somorácz A, Szász AM, Kiss A and Schaff Z: High expression of
claudin-1 protein in papillary thyroid tumor and its regional lymph
node metastasis. Pathol Oncol Res. 16:19–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abd El Atti RM and Shash LS: Potential
diagnostic utility of CD56 and claudin-1 in papillary thyroid
carcinoma and solitary follicular thyroid nodules. J Egypt Natl
Canc Inst. 24:175–184. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martin TA and Jiang WG: Loss of tight
junction barrier function and its role in cancer metastasis.
Biochim Biophys Acta. 4:872–891. 2009. View Article : Google Scholar
|
|
13
|
Miyoshi J and Takai Y: Molecular
perspective on tight-junction assembly and epithelial polarity. Adv
Drug Deliv Rev. 57:815–855. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Michl P, Barth C, Buchholz M, Lerch MM,
Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Löhr M, et al:
Claudin-4 expression decreases invasiveness and metastatic
potential of pancreatic cancer. Cancer Res. 63:6265–6271.
2003.PubMed/NCBI
|
|
15
|
Rangel LB, Agarwal R, D'Souza T, Pizer ES,
Alò PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR and Morin PJ:
Tight junction proteins claudin-3 and claudin-4 are frequently
overexpressed in ovarian cancer but not in ovarian cystadenomas.
Clin Cancer Res. 9:2567–2575. 2003.PubMed/NCBI
|
|
16
|
Soini Y: Expression of claudins 1, 2, 3,
4, 5 and 7 in various types of tumours. Histopathology. 46:551–560.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee JW, Lee SJ, Seo J, Song SY, Ahn G,
Park CS, Lee JH, Kim BG and Bae DS: Increased expressions of
claudin-1 and claudin-7 during the progression of cervical
neoplasia. Gynecol Oncol. 97:53–59. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suren D, Yildirim M, Kaya V, Elal R,
Selcuk OT, Osma U, Yildiz M, Gunduz S and Sezer C: The expression
patterns of claudin 1, 4, and 7 and their prognostic significance
in nasopharyngeal carcinoma. J BUON. 20:212–217. 2015.PubMed/NCBI
|
|
19
|
Alikanoglu AS, Gunduz S, Demirpence O,
Suren D, Gunduz UR, Sezer C, Yildiz M and Yildirim M: Expression
pattern and prognostic significance of claudin 1, 4 and 7 in
pancreatic cancer. Asian Pac J Cancer Prev. 16:4387–4392. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee JW, Hsiao WT, Chen HY, Hsu LP, Chen
PR, Lin MD, Chiu SJ, Shih WL and Hsu YC: Upregulated claudin-1
expression confers resistance to cell death of nasopharyngeal
carcinoma cells. Int J Cancer. 126:1353–1366. 2010.PubMed/NCBI
|
|
21
|
Resnick MB, Konkin T, Routhier J, Sabo E
and Pricolo VE: Claudin-1 is a strong prognostic indicator in stage
II colonic cancer: A tissue microarray study. Mod Pathol.
18:511–518. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oku N, Sasabe E, Ueta E, Yamamoto T and
Osaki T: Tight junction protein claudin-1 enhances the invasive
activity of oral squamous cell carcinoma cells by promoting
cleavage of laminin-5 gamma2 chain via matrix metalloproteinase
(MMP)-2 and membrane-type MMP-1. Cancer Res. 66:5251–5255. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Agarwal R, D'Souza T and Morin PJ:
Claudin-3 and claudin-4 expression in ovarian epithelial cells
enhances invasion and is associated with increased matrix
metalloproteinase-2 activity. Cancer Res. 65:7378–7385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Furuse M, Furuse K, Sasaki H and Tsukita
S: Conversion of zonulae occludentes from tight to leaky strand
type by introducing claudin-2 into Madin-Darby canine kidney I
cells. J Cell Biol. 153:263–272. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kominsky SL, Argani P, Korz D, Evron E,
Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP and Sukumar S:
Loss of the tight junction protein claudin-7 correlates with
histological grade in both ductal carcinoma in situ and invasive
ductal carcinoma of the breast. Oncogene. 22:2021–2033. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Usami Y, Chiba H, Nakayama F, Ueda J,
Matsuda Y, Sawada N, Komori T, Ito A and Yokozaki H: Reduced
expression of claudin-7 correlates with invasion and metastasis in
squamous cell carcinoma of the esophagus. Hum Pathol. 37:569–577.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sauer T, Pedersen MK, Ebeltoft K and Næss
O: Reduced expression of claudin-7 in fine needle aspirates from
breast carcinomas correlate with grading and metastatic disease.
Cytopathology. 16:193–198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Süren D, Yıldırım M, Kaya V, Alikanoğlu
AS, Bülbüller N, Yıldız M and Sezer C: Loss of tight junction
proteins (Claudin 1, 4, and 7) correlates with aggressive behavior
in colorectal carcinoma. Med Sci Monit. 20:1255–1262. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tzelepi VN, Tsamandas AC, Vlotinou HD,
Vagianos CE and Scopa CD: Tight junctions in thyroid
carcinogenesis: Diverse expression of claudin-1, claudin-4,
claudin-7 and occludin in thyroid neoplasms. Mod Pathol. 21:22–30.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hucz J, Kowalska M, Jarzab M and Wiench M:
Gene expression of metalloproteinase 11, claudin 1 and selected
adhesion related genes in papillary thyroid cancer. Endokrynol Pol.
57:(Suppl A). S18–S25. 2006.(In Polish).
|
